newsfilter
← Latest News
FDA Approved Drugs·

Approval of Caplyta, Nda #209500 (Efficacy)

Approval Date: 04/24/2026; Drug Name: Caplyta, Nda #209500; Active Ingredients: LUMATEPERONE TOSYLATE; Company: Intra-cellular; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 209500

Company
INTRA-CELLULAR
Keywords
INTRA-CELLULAR